TNMS Blog

Psilocybin therapy for treatment-resistant depression

Psilocybin therapy for treatment-resistant depression

October 23, 2018 COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression COMPASS Pathways, a life sciences company determined to develop cures for treatment-resistant depression based on psilocybin now received...